Price $5.28 |
Market Cap
19.9M
|
Sector Health Care |
Div. Growth
-57.10%
|
|
P/E
-
|
P/B
2.03
|
P/S
52.66
|
Dividend %
0.60%
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-
|
FCF
0.0
|
|
Op. Margin
29.60%
|
Net Margin
-254.30%
|
ROE
-9.00%
|
ROI
1.40%
|
|
ROA
-6.60%
|
EPS Growth
89.90%
|
Current Ratio
-
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.25 | - | - | 8.7M | Strong Buy |
| American Renal Associates Hold (ARA) | $19.40 | - | - | 702.9M | Strong Buy |
| Procyon Corp (PCYN) | $0.29 | - | - | 2.3M | Strong Buy |
| Digirad Corporation (DRAD) | $1.39 | - | 14.70% | 31.2M | Strong Buy |
| Assertio Therapeutics Inc (ASRT) | $5.57 | - | - | 371.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
